Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study (Q38620965)

4 September 2017

title

Persistent increase in TNF and IL-1 markers in severe mental disorders suggests trait-related inflammation: a one year follow-up study (English)

1 reference

4 September 2017

0 references

I Joa

10

0 references

Gunnar Morken

G Morken

11

0 references

Pål Aukrust

13

P Aukrust

1 reference

4 September 2017

16

T Ueland

1 reference

4 September 2017

15

I Melle

1 reference

4 September 2017

Erlend Strand Gardsjord

7

E S Gardsjord

1 reference

4 September 2017

S Hope

4

0 references

Srdjan Djurovic

S Djurovic

14

0 references

Ingrid Agartz

12

I Agartz

1 reference

4 September 2017

17

O A Andreassen

1 reference

4 September 2017

R H Mørch

1

1 reference

4 September 2017

I Dieset

2

1 reference

4 September 2017

A Faerden

3

1 reference

4 September 2017

M Aas

5

1 reference

4 September 2017

M Nerhus

6

1 reference

4 September 2017

M Haram

8

1 reference

4 September 2017

R S Falk

9

1 reference

4 September 2017

language of work or name

English

0 references

publication date

16 August 2017

1 reference

Acta Psychiatrica Scandinavica

4 September 2017

published in

1 reference

Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment

4 September 2017

cites work

1 reference

Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis

21 January 2018

1 reference

Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review

21 January 2018

1 reference

Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis

21 January 2018

1 reference

Inflammation and schizophrenia

21 January 2018

1 reference

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort

21 January 2018

1 reference

Serological documentation of maternal influenza exposure and bipolar disorder in adult offspring

21 January 2018

1 reference

Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.

21 January 2018

1 reference

Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia

21 January 2018

1 reference

Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population.

21 January 2018

1 reference

Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study

21 January 2018

1 reference

Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study

21 January 2018

1 reference

Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group

21 January 2018

1 reference

Inflammatory markers are associated with general cognitive abilities in schizophrenia and bipolar disorder patients and healthy controls

21 January 2018

1 reference

Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia

21 January 2018

1 reference

21 January 2018

1 reference

Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder

21 January 2018

1 reference

Inflammatory evidence for the psychosis continuum model

21 January 2018

1 reference

Remission in schizophrenia: proposed criteria and rationale for consensus

21 January 2018

1 reference

Osteoprotegerin levels in patients with severe mental disorders

21 January 2018

1 reference

Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci

21 January 2018

1 reference

Biological insights from 108 schizophrenia-associated genetic loci

21 January 2018

1 reference

Schizophrenia risk from complex variation of complement component 4

21 January 2018

1 reference

Cytokines and the neurodevelopmental basis of mental illness

21 January 2018

1 reference

Is there a role for immune-to-brain communication in schizophrenia?

21 January 2018

1 reference

Longitudinal changes in total brain volume in schizophrenia: relation to symptom severity, cognition and antipsychotic medication

21 January 2018

1 reference

Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans

21 January 2018

1 reference

The role of inflammation in depression: from evolutionary imperative to modern treatment target

21 January 2018

1 reference

The Phenomenology of Major Depression and the Representativeness and Nature of DSM Criteria

21 January 2018

1 reference

Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors

21 January 2018

1 reference

Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels

21 January 2018

1 reference

Pro-cognitive properties of T cells

21 January 2018

1 reference

Neuroimmune biomarkers in schizophrenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ACPS.12783

1 reference

4 September 2017

1 reference